artesunic acid has been researched along with Recrudescence in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.96) | 18.7374 |
| 1990's | 11 (21.57) | 18.2507 |
| 2000's | 23 (45.10) | 29.6817 |
| 2010's | 13 (25.49) | 24.3611 |
| 2020's | 3 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chaoratanakawee, S; Chin, G; Harrison, D; Lek, D; Menard, D; Rachmat, A; Rogers, WO; Saunders, D | 1 |
| Baird, JK; Cui, L; He, X; Huang, Y; Lu, Y; Pan, M; Pi, L; Qin, P; Qin, Y; Yang, Z; Zeng, W; Zhao, L; Zou, C | 1 |
| Blessborn, D; Byakika-Kibwika, P; Lamorde, M; Ssenyonga, R; Tarning, J | 1 |
| Abraham, P; Argaud, L; Becker, A; Bienvenu, AL; Bonnot, G; Chidiac, C; Conrad, A; Kouakou, YI; Landre, S; Leboucher, G; Miailhes, P; Picot, S; Rimmelé, T; Simon, M | 1 |
| Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
| Buyze, J; D'Alessandro, U; Hachizovu, S; Kabuya, JB; Kasongo, W; Mulenga, J; Mulenga, M; Mwakazanga, D; Nambozi, M; Van Geertruyden, JP | 1 |
| Chang, ZW; Claser, C; Rénia, L; Russell, B | 1 |
| Hasegawa, C; Kimura, M; Kudo, M; Maruyama, H | 1 |
| Aung, AA; Bancone, G; Carrara, VI; Cheah, PY; Chu, CS; Chue, AL; Imwong, M; Lwin, KM; Moore, KA; Nosten, F; Phyo, AP; Proux, S; Raksapraidee, R; San, T; Sriprawat, K; Tarning, J; Watson, J; White, NJ; Wiladphaingern, J; Win, HH; Winterberg, M | 1 |
| Aouri, M; Carn, G; Csajka, C; Decosterd, LA; Guidi, M; Kiechel, JR; Mercier, T; Ogutu, B | 1 |
| Ariey, F; Duong, S; Kiechel, JR; Leang, R; Lim, P; Ménard, D; Navaratnam, V; Ros, S; Taylor, WR | 1 |
| Aguirre-Acevedo, DC; Tamayo Perez, ME; Zuluaga-Idarraga, LM | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| An, SS; Ariey, F; Chotivanich, K; Das, D; Day, NP; Dondorp, AM; Hanpithakpong, W; Herdman, T; Imwong, M; Lee, SJ; Lim, P; Lindegardh, N; Lwin, KM; Nosten, F; Phyo, AP; Ringwald, P; Silamut, K; Singhasivanon, P; Socheat, D; Tarning, J; White, NJ; Yeung, S; Yi, P | 1 |
| Biggs, BA; Casey, GJ; Cowman, AF; Hung, NM; Phuc, BQ; Thanh, NV; Tien, NT; Toan, TQ | 1 |
| Nosten, F | 1 |
| Alonso, PL; Bassat, Q; Betuela, I; de Lazzari, E; Del Portillo, HA; Kiniboro, B; Mueller, I; Rosanas-Urgell, A; Samol, L; Siba, P; Stanisic, DI | 1 |
| Bhatt, KM; Borghini-Fuhrer, I; Bustos, MD; de Salazar, PM; Doumbo, OK; Duparc, S; Fleckenstein, L; Kayentao, K; Kimani, J; Kokolomami, JH; Offianan, AT; Ouédraogo, A; Pénali, LK; Quicho, F; Ramharter, M; Shin, CS; Tiono, AB; Tshefu, AK | 1 |
| Dyk Dao, L; Rabinovich, SA; Van Ha, N | 1 |
| Adegnika, AA; Binder, RK; Borrmann, S; Issifou, S; Kremsner, PG; Krishna, S; Kun, JF; Lell, B; Matsiegui, PB; Missinou, MA; Schindler, A | 1 |
| Cattamanchi, A; Dorsey, G; Hubbard, A; Kyabayinze, D; Rosenthal, PJ | 1 |
| Emery, K; Ittarat, W; Looareesuwan, S; Low, J; Meshnick, SR; Pickard, AL; Rattanasinganchan, P; Udomsangpetch, R; Wilairatana, P | 1 |
| Cabezas, C; Calampa, C; Falconí, E; Huilca, M; Marquiño, W; Naupay, R; Ruebush, TK | 1 |
| Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
| Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
| Imwong, M; Krudsood, S; Looareesuwan, S; Nonprasert, A; Pukrittayakamee, S; Snounou, G; White, NJ; Wilairatana, P | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI; Idris, SM; Malik, EM | 1 |
| A/elbasit, IA; Adam, I; Elbashir, MI; Ibrahim, MH | 1 |
| Counillon, E; Del Giudice, P; Delaunay, P; Vandenbos, F | 1 |
| Ashley, E; Aye, KZ; Barends, M; Htet, L; Kyaw, MK; Lindegardh, N; Lwin, S; Phe, O; Singtoroj, T; Smithuis, F; Stepniewska, K; White, NJ | 1 |
| Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Stepniewska, K; Thongpraseuth, V; White, NJ | 1 |
| Adjuik, M; Beck, HP; Mshinda, H; Mugittu, K; Ntoumi, F; Olliaro, P; Snounou, G; Taylor, W | 1 |
| Adam, I; Alifrangis, M; Elmardi, KA; Khalil, IF; Magzoub, M; Osman, ME | 1 |
| Chappuis, F; Jackson, Y; Loutan, L; Taylor, W | 1 |
| Adjuik, M; Beck, HP; Guthmann, JP; Kiguli, J; Mshinda, H; Mugittu, K; Olliaro, PL; Priotto, G; Snounou, G; Taylor, WR | 1 |
| Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
| Cao, YM; Chen, G; Feng, H; Guo, SY; Li, DM; Liu, YJ; Ma, SH; Wang, JC; Zheng, L | 1 |
| Alker, AP; Ariey, F; Bouth, DM; Fandeur, T; Lim, P; Maguire, JD; Meshnick, SR; Sem, R; Shah, NK; Tsuyuoka, R; Wongsrichanalai, C; Yi, P | 1 |
| Chongsuphajaisiddhi, T; Eh, JP; Luxemburger, C; Nosten, F; ter Kuile, FO; White, NJ; Woodrow, C | 1 |
| Canfield, CJ; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
| Attanath, P; Brewer, TG; Chanthavanich, P; Chongsuphajaisiddhi, T; Heppner, DG; Mookmanee, D; Phanuaksook, P; Poonpanich, Y; Prarinyanupharb, V; Sabchareon, A; Teja-Isavadharm, P | 1 |
| Bian, WX; Fu, YX; Li, GQ | 1 |
| Brockman, A; Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Phaipun, L; Price, R; van Vugt, M; White, N | 1 |
| de Vries, PI; Ho, PL; Kager, PA; Le, NH; Le, TD; Nguyen, VN; Trinh, KA | 1 |
| Anh, CV; Davis, TM; Giang, LT; Hang, NT; Hewitt, S; Quang, HH; Thoa, NT; Thuan, LK; Thuy, PT; Trung, TN; Tuan, NT | 1 |
| Canfield, CJ; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Webster, HK; Wilairatana, P | 1 |
| Bunnag, D; Harinasuta, T; Karbwang, J; Looareesuwan, S; Viravan, C | 3 |
| Feng, TG; Guo, XB; Li, GQ; Li, PS; Shi, WZ; Wang, HF; Zhang, SF | 1 |
2 review(s) available for artesunic acid and Recrudescence
| Article | Year |
|---|---|
Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Child, Preschool; Humans; Malaria, Falciparum; Mefloquine; Randomized Controlled Trials as Topic; Recurrence | 2022 |
Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Administration Schedule; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Recurrence; Secondary Prevention | 2015 |
28 trial(s) available for artesunic acid and Recrudescence
| Article | Year |
|---|---|
Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
Topics: Administration, Intravenous; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Osmolar Concentration; Plasmodium falciparum; Quinine; Quinolines; Recurrence; Treatment Outcome; Uganda | 2019 |
Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Mefloquine; Pregnancy; Quinolines; Recurrence; Risk; Treatment Outcome; Young Adult; Zambia | 2017 |
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
Topics: Adolescent; Adult; Antimalarials; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Vivax; Male; Middle Aged; Myanmar; Parasitemia; Plasmodium vivax; Primaquine; Recurrence; Thailand; Treatment Outcome; Young Adult | 2018 |
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Topics: Antimalarials; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Recurrence | 2019 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
Artemisinin resistance in Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Recurrence; Young Adult | 2009 |
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Primaquine; Recurrence; Risk Factors; Time Factors | 2012 |
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Dosage Forms; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Naphthyridines; Parasite Load; Recurrence; Tablets; Treatment Outcome | 2012 |
Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Recurrence; Sesquiterpenes; Treatment Outcome; Vomiting | 2003 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Efficacy of sulfadoxin pyrimethamine for uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasite Egg Count; Parasitic Sensitivity Tests; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Recurrence; Seasons; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure | 2004 |
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinolines; Recurrence; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Humans; Malaria, Falciparum; Patient Selection; Plasmodium falciparum; Pyrimethamine; Recurrence; Sesquiterpenes; Sudan; Sulfalene; Treatment Failure; Treatment Outcome | 2006 |
Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Genes, Protozoan; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Uganda | 2007 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
Topics: Adolescent; Adult; Aged; Animals; Artemisinins; Artesunate; Cambodia; Child; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Recurrence; Sesquiterpenes; Thailand | 2007 |
Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Plasmodium falciparum; Recurrence; Sesquiterpenes; Thailand; Time Factors | 1994 |
Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Recurrence; Sesquiterpenes | 1994 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Pilot Projects; Recurrence; Sesquiterpenes; Suppositories; Thailand | 1998 |
[Comparison on treatment of falciparum malaria with different courses of artesunate tablet].
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Recurrence; Sesquiterpenes; Tablets | 1997 |
Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Recurrence; Sesquiterpenes; Treatment Failure | 1998 |
Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Recurrence; Regression Analysis; Sesquiterpenes; Statistics, Nonparametric; Vietnam | 2001 |
Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report.
Topics: Administration, Oral; Adolescent; Adult; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Hospitals, University; Humans; Injections, Intramuscular; Injections, Intravenous; Leukopenia; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Recurrence; Sesquiterpenes; Thailand | 1991 |
Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Malaria, Falciparum; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Sesquiterpenes; Time Factors | 1991 |
Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Follow-Up Studies; Humans; Malaria, Falciparum; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Sesquiterpenes; Time Factors | 1991 |
21 other study(ies) available for artesunic acid and Recrudescence
| Article | Year |
|---|---|
Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Cytochrome P-450 CYP2D6; Ghana; Humans; Inactivation, Metabolic; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Recurrence | 2019 |
Recrudescence of a high parasitaemia, severe Plasmodium falciparum malaria episode, treated by artesunate monotherapy.
Topics: Aged; Antimalarials; Artesunate; Humans; Malaria, Falciparum; Male; Parasitemia; Recurrence | 2021 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Adaptive immunity is essential in preventing recrudescence of Plasmodium yoelii malaria parasites after artesunate treatment.
Topics: Adaptive Immunity; Animals; Antimalarials; Artemisinins; Artesunate; B-Lymphocytes; CD4-Positive T-Lymphocytes; Disease Models, Animal; Drug Resistance; Female; Malaria; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Plasmodium yoelii; Recurrence | 2017 |
Severe delayed haemolytic anaemia associated with artemether-lumefantrine treatment of malaria in a Japanese traveller.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Hemolytic; Antimalarials; Artemether; Artemisinins; Artesunate; Blackwater Fever; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Plasmodium vivax; Recurrence; Young Adult | 2018 |
Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Combinations; Female; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Young Adult | 2013 |
Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Female; Follow-Up Studies; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Sensitivity and Specificity; Time Factors; Vietnam; Young Adult | 2010 |
Waking the sleeping beauty.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Microbial Viability; Plasmodium falciparum; Recurrence | 2010 |
Use of nested PCR for differential diagnosis of falciparum malaria reinfection and relapse in drug-resistant patients.
Topics: Alleles; Animals; Antimalarials; Artemisinins; Artesunate; Diagnosis, Differential; DNA, Protozoan; Drug Resistance, Multiple; Genes, Protozoan; Genetic Markers; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Recurrence; Sesquiterpenes; Time Factors | 2002 |
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Gabon; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Treatment Outcome | 2003 |
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure; Uganda | 2003 |
Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; ATP-Binding Cassette Transporters; Cohort Studies; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Recurrence; Retrospective Studies; Sesquiterpenes; Thailand | 2003 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Dihydropteroate Synthase; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Proguanil; Prospective Studies; Recurrence; Sesquiterpenes; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
[Relapse of Plasmodium falciparum malaria in a patient treated with artesunate].
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Falciparum; Mefloquine; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness.
Topics: Africa South of the Sahara; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Randomized Controlled Trials as Topic; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Cote d'Ivoire; Dose-Response Relationship, Drug; Drug Labeling; Ethanolamines; Female; Fluorenes; Guidelines as Topic; Guinea; Humans; Lactones; Lumefantrine; Malaria, Falciparum; Parasitemia; Recurrence; Risk; Sesquiterpenes; Sudan; Switzerland; Treatment Failure; World Health Organization | 2006 |
Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Female; Immunoglobulin G; Interferon-gamma; Malaria; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Parasitemia; Plasmodium yoelii; Recurrence; Sesquiterpenes | 2007 |
Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Azithromycin; Developing Countries; Drug Administration Schedule; Humans; Malaria, Falciparum; Male; Pilot Projects; Recurrence; Sesquiterpenes; Treatment Outcome; Vietnam | 1999 |
Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prospective Studies; Recurrence; Sesquiterpenes | 1992 |
[Clinical study on the treatment of malaria with artemether and artesunate].
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrans; Recurrence; Sesquiterpenes | 1988 |